Catlin and Landis will be testifying tomorrow, probably in this order:
Witness list for Saturday, May 19
Wilhelm Schnäzer, Phd (telephone)
Director. Institute of Biochemistry of the German Sports University Cologne
Don H. Catlin, M.D.
Professor Emeritus of Molecular and Medical Pharmacology and former founder and director, Olympic Analytical Laboratory, UCLA
The USADA briefs on the case are available on the USOC site, a little earlier than the Landis Brief.
|05/18/2007||FLOYD LANDIS HEARING / USADA's response brief to Landis' motion to exclude sample B results||USOC/Susan Polakoff|
|05/18/2007||FLOYD LANDIS HEARING / USADA's pre-trial response brief||USOC/Susan Polakoff|
|05/18/2007||FLOYD LANDIS HEARING / USADA'S pre-hearing brief||USOC/Susan Polakoff|
|05/18/2007||FLOYD LANDIS HEARING / USADA's position re: further anaylsis of other samples|
|05/18/2007||FLOYD LANDIS HEARING / Resondent's pre-trial brief||USOC/Susan Polakoff|
|05/18/2007||FLOYD LANDIS HEARING / Witness list for Saturday May 19||USOC/Susan Polakoff|
USADA's briefs take the pre-trial public defense seriously, and argue for a single metabolite standard at -3.0 delta-delta units.
Landis' brief argues for a multi-metabolite, -3.0 PLUS uncertainty, and promised more based on evidence obtained late in the game, these being filed before all the material from "reprocessing" was available.
Neither spends much time on the T/E.
As with all briefs, they seem pretty convincing when you read one, then you read the other, and it sounds right too.